These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9774821)

  • 1. [Therapeutic failure, treatment and non-treatment of childhood epilepsy].
    Garaizar C; Pérez-García J; Gil-Antón J; Prats JM
    Rev Neurol; 1998 Sep; 27(157):467-72. PubMed ID: 9774821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy].
    Szwed-Białozyt B; Marszał E
    Przegl Lek; 2003; 60 Suppl 1():5-9. PubMed ID: 12945154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F; Sopranzi N
    Clin Ter; 1998; 149(2):131-4. PubMed ID: 9780478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-drug treatment failures in children newly diagnosed with epilepsy.
    Dudley RW; Penney SJ; Buckley DJ
    Pediatr Neurol; 2009 Feb; 40(2):71-7. PubMed ID: 19135617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of newly diagnosed epileptic crises. A French experience].
    Groupe CAROLE (Coordination Active du Réseau Observatoire Longitudinal de l'Epilepsie)
    Rev Neurol (Paris); 2001 Dec; 157(12):1500-12. PubMed ID: 11924446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of treatment and selection of antiepileptic drugs in childhood epilepsy.
    Oka E; Murakami N; Ogino T; Kobayashi K; Ohmori I; Akiyama T; Ito M
    Epilepsia; 2004; 45 Suppl 8():17-9. PubMed ID: 15610189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of antiepileptic drugs in an Omani epileptic population.
    Hanssens Y; Al-Asmi A; Al-Busaidi I; Deleu D
    Clin Neurol Neurosurg; 2006 Sep; 108(6):532-8. PubMed ID: 16169660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
    Irshaid YM; Hamdi AA; Al Homrany M
    Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vigabatrin: results with a new antiepileptic agents in 57 patients in a general neurological practice].
    van der Zwan A; van der Zwan A
    Ned Tijdschr Geneeskd; 1994 Sep; 138(37):1859-63. PubMed ID: 7935922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Computerized stabilometry in the monitoring of antiepileptic therapy in children].
    Franzoni E; Crisanti AF; Arcuri S; Buccolieri M; Bergonzoni C
    Pediatr Med Chir; 1995; 17(5):407-9. PubMed ID: 8684994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal nerve fiber layer and macular thickness in adolescents with epilepsy treated with valproate and carbamazepine.
    Lobefalo L; Rapinese M; Altobelli E; Di Mascio R; Lattanzi D; Gallenga PE; Chiarelli F; Verrotti A
    Epilepsia; 2006 Apr; 47(4):717-9. PubMed ID: 16650137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological outcomes in newly diagnosed epilepsy.
    Mohanraj R; Brodie MJ
    Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Idiopathic epilepsies: some therapeutic aspects].
    Campos-Castelló J; Prats Viñas JM; García-Ribes A
    Rev Neurol; 2004 Jan 16-31; 38(2):180-4. PubMed ID: 14752722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Remission of epilepsy after onset of antiepileptic treatment: a prospective study in childhood].
    Ramos-Lizana J; Cassinello-García E; Carrasco-Marina L; Vázquez-López M; Martín-González M; Muñoz-Hoyos A
    Rev Neurol; 2001 Dec 1-15; 33(11):1021-6. PubMed ID: 11785027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
    Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A
    Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
    Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
    Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
    Steinborn B
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New antiepileptic drugs in childhood epilepsies: indications and limits].
    Kaminska A
    Epileptic Disord; 2001; 3 Spec No 2():SI37-46. PubMed ID: 11827845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.